Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Ruoff

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Atherosclerosis|January 24, 2007
Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)James M McKenney, Peter H Jones, Harold E Bays, et al.
Mayo Clinic Proceedings|February 9, 2007
Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migrainePaul Winner, Roger K Cady, Gary E Ruoff, et al.
The Journal of Family Practice|October 15, 2009
Short- and long-term management of heartburn and other acid-related disorders: development of an algorithm for primary care providersM Brian Fennerty, Karen B Finke, Pamela R Kushner, et al.
Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Atherosclerosis|January 24, 2007
Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)James M McKenney, Peter H Jones, Harold E Bays, et al.
Mayo Clinic Proceedings|February 9, 2007
Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migrainePaul Winner, Roger K Cady, Gary E Ruoff, et al.
The Journal of Family Practice|October 15, 2009
Short- and long-term management of heartburn and other acid-related disorders: development of an algorithm for primary care providersM Brian Fennerty, Karen B Finke, Pamela R Kushner, et al.
Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.
Pageof 2